XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues $ 34,565 $ 55,147 $ 76,099 $ 170,278
Costs and expenses:        
Cost of sales (excluding amortization of intangible assets) 6,462 2,243 13,099 6,942
Research and development expenses 1,316 1,476 3,983 4,531
Selling, general and administrative expenses 25,746 36,117 81,191 85,917
Amortization of intangible assets 5,587 25,444 18,237 76,331
Restructuring charges 268 0 6,787 0
Total costs and expenses 39,379 65,280 123,297 173,721
Loss from operations (4,814) (10,133) (47,198) (3,443)
Other income (expense):        
Interest expense (3,050) (13,872) (13,328) (45,268)
Change in fair value of contingent consideration (1,861) 0 (1,861) 0
Other gain (loss) 253 (764) (3,571) (2,613)
Total other (expense) income (4,658) 11,749 37,033 (21,496)
Net (loss) income before income taxes (9,472) 1,616 (10,165) (24,939)
Income tax (expense) benefit (1,050) 1,715 6,374 364
Net (loss) income (10,522) 3,331 (3,791) (24,575)
Comprehensive (loss) income $ (10,522) $ 3,331 $ (3,791) $ (24,575)
Basic and diluted net (loss) income per share (in dollars per share) $ (0.09) $ 0.05 $ (0.04) $ (0.36)
Shares used in computing basic and diluted net (loss) income per share (in shares) 119,564 72,747 99,832 67,332
Convertible notes        
Other income (expense):        
(Loss) Gain on extinguishment and prepayment of debt $ 0 $ 26,385 $ (47,880) $ 26,385
Senior Notes        
Other income (expense):        
(Loss) Gain on extinguishment and prepayment of debt 0 0 (8,233) 0
Product sales, net        
Revenues:        
Total revenues 34,266 27,502 63,683 79,889
Commercialization agreement, net        
Revenues:        
Total revenues 0 27,304 11,258 89,163
Royalties and milestones        
Revenues:        
Total revenues 299 341 1,158 1,226
Gralise        
Revenues:        
Total revenues   14,900 400 46,000
Other income (expense):        
Loss (Gain) on sale of assets 0 0 126,655 0
NUCYNTA        
Other income (expense):        
Loss (Gain) on sale of assets $ 0 $ 0 $ (14,749) $ 0